| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |